Catalog

Contact Hour(s): 

1 Contact hour, including 1 Advanced Pharmacology Hour

Author:

David Tilton, RN, BSN

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Athletic Trainer (AT/AL), Certified Medication Assistant (CMA), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Nursing Assistant (CNA), Certified Registered Nurse Anesthetist (CRNA), Clinical Nurse Specialist (CNS), Dietetic Technicians, Registered (DTR), Dietitian/Nutritionist (RDN), Electrologist (EO), Home Health Aid (HHA), Licensed Nursing Assistant (LNA), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Medical Assistant (MA), Medication Aide, Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Pedorthist (PED), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner, Respiratory Care Practitioner, Respiratory Therapist (RT)

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA), Board of Certification for Athletic Trainers (BOC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; New York State Education Department’s State Board for Physical Therapy

Course Description:

This course discusses the Human Immunodeficiency Virus (HIV) and its end-stage Acquired Immunodeficiency Syndrome (AIDS), along with strategies for extending the disease process and allowing for a high-quality life despite the presence of an otherwise terminal disease.

Outcomes

≥ 92% of participants will know the most current, evidence-based information about HIV and AIDS.

Objectives

After completing this continuing education course, the participant will be able to:

1. Identify the civil rights of the HIV/AIDS-infected individual and their family/friends.

2. Explain the current incidence of HIV.

3. Describe the modes of transmission of HIV and various strategies to prevent the spread of HIV.

4. Examine the pathophysiologic changes in the human body following HIV infection.

5. Compare and contrast current medication modalities prescribed for HIV

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s):

2 Contact Hours

Author:

Celeste Barefield, MSN, APRN, FNP-BC

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353

Course Description:

This course discusses the etiology of the ubiquitous catheter-associated urinary tract infection (CAUTI), including prevention methods.

Outcomes

≥ 92% of participants will know the main uropathogens in catheter-associated urinary tract infections (CAUTIs) and medical care guidelines for this infection.

Objectives

After completing this continuing education course, the participant will be able to:

1. Recall new material about urinary catheters and catheter-associated urinary tract infections (CAUTIs).
2. Define CAUTI and identify its risk factors in different medical settings.
3. Identify current evidence-based practices to prevent CAUTIs.
4. Assess the effectiveness of CAUTI prevention strategy bundles.
5. Outline the latest research on new technologies and approaches to urinary catheterization and their potential impact on CAUTI rates.
6. Acquire tools to advocate for policies and practices that support CAUTI prevention and antimicrobial stewardship principles.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

2 Contact Hours

Author:

Krystle Maynard, DNP, RN, SANE-A

This peer-reviewed course is applicable for the following professions: 

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN), Respiratory Care Practitioner, Respiratory Therapist (RT)

Accreditations: 

The American Nurses Credentialing Center (ANCC),

Course Description:

This course discusses the impact of the Ebola virus, how it is transmitted, treatment modalities, potential complications, proper personal protective equipment, and infection control mitigation requirements.

Outcomes:

≥ 92% of participants will know how to identify specific risk factors for Ebola virus disease, modes of transmission, and proper infection control and mitigation steps.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Summarize modes of transmission of the Ebola virus.
2. Identify the clinical manifestations of the Ebola virus, including symptomology and laboratory values.
3. Describe treatment options for patients with suspected or confirmed Ebola virus disease.
4. Outline strategies to prevent the spread of the Ebola virus.
5. List long-term complications which may persist after surviving the Ebola virus.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

(Does not meet NYSED requirements)

Contact Hour(s): 

2.5 Contact hours

Author:

Dana Bartlett, RN, BSN, MA, MA, CSPI

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Athletic Trainer (AT/AL), Certified Medication Assistant (CMA), Certified Nursing Assistant (CNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Dietetic Technicians, Registered (DTR), Dietitian/Nutritionist (RDN), Home Health Aid (HHA), Licensed Nursing Assistant (LNA), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Medical Assistant (MA), Medication Aide, Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Respiratory Care Practitioner, Respiratory Therapist (RT)

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA), Board of Certification for Athletic Trainers (BOC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-1095980; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; Nevada Board of Physical Therapy; New York State Education Department’s State Board for Physical Therapy

Course Description:

This course discusses 1) The process of transmission of infectious pathogens, 2) Basic infection control procedures and techniques, 3) How specific infectious pathogens are transmitted and the infection control procedures/techniques used to prevent their transmission, 4) Hospital-acquired infections – e.g.., specific pathogens like influenza and pneumonia, 5) Treatment of occupational exposure to hepatitis B (HBV), hepatitis C (HCV), and HIV, and 6) Sepsis.

Outcomes

≥ 92% of participants will know basic infection control procedures and techniques.

Objectives

After completing this continuing education course, the participant will be able to:

1. Explain critical definitions related to infection control.
2. Explain the components of various infection precautions.
3. Evaluate when specific PPE should be used.
4. Summarize risk factors that increase susceptibility to various infections.
5. Specify signs and symptoms of various infections.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

1 Contact Hour

Author: 

Heather Rhodes, APRN-BC)

This peer-reviewed course is applicable for the following professions: 

Advanced Practice Registered Nurse (APRN), Athletic Trainer (AT/AL), Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC); The American Occupational Therapy Association (AOTA), Board of Certification for Athletic Trainers (BOC)

State Approvals: 

 Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; Nevada Board of Physical Therapy; New York State Education Department’s State Board for Physical Therapy;   

Course Description: 

Malaria is a significant and deadly global health problem affecting millions yearly. It is a deadly disease that can be prevented; therefore, it is essential to understand malaria transmission. This course discusses epidemiology, symptomatology, and treatment of malaria.

Outcomes: 

≥92% of participants will know how malaria is transmitted and understand ways to prevent the transmission of malaria.

Objectives: 

After completing this course, the participant will be able to:

1. Describe malaria.
2. Outline the epidemiology of malaria.
3. Identify ways to prevent malaria.
4. Determine the symptomatology of malaria.
5. Summarize the treatment options for malaria

Disclosures: 

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

2 Contact Hours including 2 Pharmacology Hours

Author:

Sarah Schulze, MSN, APRN, CPNP, PMHS, CLC

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353

Course Description:

This course discusses the pathophysiology of measles, its risks and complications, and the progression of this disease’s effects on society throughout history, both before and after available vaccination.

Outcomes:

≥ 92% of participants will know how to identify and treat measles.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Identify risk factors for measles infection.
2. Explain the effects on global and local infection rates after introducing the measles vaccine.
3. Summarize the history of measles in North America.
4. Characterize how measles outbreaks continue to occur in the United States.
5. Describe how the measles virus was first isolated for vaccine development.
6. Differentiate between the original measles vaccine and the one currently used today.
7. Utilize current recommendations to create a vaccine plan.
8. Explain how the measles virus attacks and spreads through a host.
9. Paraphrase the transmissibility of measles.
10. Identify signs and symptoms of measles at various points in the infection process.
11. Explain the diagnostics used to confirm suspected measles cases.
12. Identify treatment interventions for patients with acute measles infection.
13. Explain the effects of the anti-vaccine movement on measles infection rates.
14. Outline how the COVID-19 pandemic has affected vaccination rates for measles.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

2 Contact Hours

Author:

Heather Rhodes, APRN-BC

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Athletic Trainer (AT/AL), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA), Board of Certification for Athletic Trainers (BOC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-1293970; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; Nevada Board of Physical Therapy; New York State Education Department’s State Board for Physical Therapy

Course Description:

This course discusses how stigma, discrimination, and bias have drastic impacts on people living with HIV/AIDs. There are no clear guidelines on how to create and maintain a stigma and discrimination-free milieu. This course is designed to bring awareness to this. Stigma, discrimination, and bias toward patients with HIV persist globally, leading to social exclusion, inadequate healthcare, and mental health challenges. Addressing these issues requires education, policy changes, and societal awareness.

Outcomes:

≥ 92% of participants will know how to identify stigma, discrimination, and bias, as well as how to prevent the impact these have on patients who have been diagnosed with HIV/AIDS.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Explain the meaning of stigma, discrimination, and bias.
2. Identify three risk factors for developing human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS).
3. Determine three ways stigma, discrimination, and bias negatively impact people with HIV/AIDS.
4. Recognize four different forms of stigma, discrimination, and bias.
5. Outline two strategies to combat stigma, discrimination, and bias.
6. Compare two ways to recognize implicit bias.
7. Identify one strategy a healthcare provider can implement to prevent implicit bias in an organization or institution.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

2 Contact Hours, including 2 Advanced Pharmacology Hours

Author:

Heather Rhodes, APRN-BC

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Athletic Trainer (AT/AL), Certified Registered Nurse Anesthetist (CRNA), Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Respiratory Therapist (RT)

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA), Board of Certification for Athletic Trainers (BOC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; Nevada Board of Physical Therapy; New York State Education Department’s State Board for Physical Therapy

Course Description:

This course discusses the epidemiology, symptomatology, and treatment of tick-borne disease.

Outcomes:

≥ 92% of participants will know how tick-borne disease is transmitted and understand the treatment of tick-borne diseases.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Describe the epidemiology of tick-borne disease.
2. Describe ways to prevent tick-borne disease.
3. Identify the symptomology of a tick-borne disease.
4. Explain three common lab findings for tick-borne diseases.
5. Summarize two treatment options for tick-borne disease.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.